Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
– Sell
-18,272
Closed -$44.6K – 437
2024
Q3
$44.6K Buy
18,272
+1,015
+6% +$2.28K ﹤0.01% 442
2024
Q2
$40.2K Buy
17,257
+4,602
+36% +$10.5K ﹤0.01% 437
2024
Q1
$31.4K Sell
12,655
-1,631
-11% -$4.25K ﹤0.01% 382
2023
Q4
$40K Buy
14,286
+3,051
+27% +$8.24K ﹤0.01% 347
2023
Q3
$29K Sell
11,235
-1,220
-10% -$3.53K ﹤0.01% 317
2023
Q2
$39.6K Sell
12,455
-7
-0.1% -$21 0.01% 315
2023
Q1
$35.1K Sell
12,462
-588
-5% -$1.54K 0.01% 304
2022
Q4
$35.5K Sell
13,050
-625
-5% -$1.82K 0.01% 293
2022
Q3
$39K Buy
13,675
+2,823
+26% +$8.01K 0.01% 250
2022
Q2
$32K Buy
+10,852
New +$30.9K 0.01% 258
2022
Q1
– Sell
-12,369
Closed -$35K – 269
2021
Q4
$35K Hold
12,369
– – ﹤0.01% 273
2021
Q3
$34K Sell
12,369
-317
-2% -$1K ﹤0.01% 264
2021
Q2
$44K Sell
12,686
-1,357
-10% -$4.42K ﹤0.01% 271
2021
Q1
$38K Buy
+14,043
New +$39.7K ﹤0.01% 280

Other funds holding ABEV

Keel Point's ABEV Position: Q4 2024 in Review

Keel Point sold out of Ambev (ABEV) in Q4 2024, closing a stake of 18,272 shares — an estimated $44.6K sold.

Keel Point first reported a position in ABEV in Q1 2021 and held it in 14 quarters. The position peaked at $44.6K in Q3 2024. 399 funds tracked by Wall St. Rank hold ABEV as of Q4 2024.

  • Keel Point reported no remaining Ambev position as of Q4 2024 after selling out during the quarter.
  • Keel Point sold 18,272 Ambev shares in Q4 2024, an estimated $44.6K.
  • Keel Point first reported a position in Ambev in Q1 2021 and held it in 14 quarters.
  • Keel Point's Ambev position peaked at $44.6K in Q3 2024.
  • 399 funds tracked by Wall St. Rank held Ambev as of Q4 2024.

Based on Keel Point's 13F filing for Q4 2024, filed 14 Feb 2025.